PATENT CLAIM ANALYSIS

Application Number: 15945606
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["514", "475000"]

Abstract:
The present invention relates to a pharmaceutical composition for preventing or treating autoimmune diseases having cedrol or a pharmaceutically acceptable salt thereof as an active ingredient. Particularly, the cedrol or the derivative thereof of the present invention inhibits the expression of IL-17A, and in particular, cedrol, cedryl acetate, and cedrene exhibit the effect of delaying the outbreak of psoriasis and treating thereof in a psoriasis animal model. Therefore, these compounds can be used for the treatment of autoimmune diseases mediated by IL-17.

Claim (Index 4):
The method of treating autoimmune diseases according to  claim 1 , wherein the autoimmune disease is Crohn's disease, inflammatory bowel disease, type 1 diabetes, or asthma caused by the excessive secretion of IL-17 in the digestive tracts or the respiratory system.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 91.0
- Lexical Diversity: 1.625
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15945601', '15545427', '14369467', '15258263', '15680449']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7721550124182043
- 35 USC 102 Novelty (BERT): 0.6084495301213559
- Combined Prediction Score: 0.7557844641885194
- Mean Citation Score: 333.741044
- Max Citation Score: 679.342
- Similarity Product: 444.8576377327442

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test